GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dimed SA Distribuidora de Medicamentos PNVL3.SA · BRL

Consumer Staples · B3 · 🇧🇷 Brazil

Compare

11.07

-2.64%

Close of 9 Nov 2026, in BRL

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Dimed SA Distribuidora de Medicamentos

Its shares trade on B3 under the ticker PNVL3.SA. It has been listed since 29 October 1992. In the fiscal year to 31 December 2025, it reported revenue of BRL 5.51bn and net income of BRL 124.6m. At that date it held total assets of BRL 3.83bn and shareholders' equity of BRL 1.28bn.

Dimed SA Distribuidora de Medicamentos engages in the marketing, distribution and sale of medicines and cosmetics. The company is headquartered in Eldorado Do Sul, Rio Grande Do Sul. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. The company organizes its business into two main segments: Medicine and Perfumery. The firm provides retail and wholesale distribution. The firm owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Listed since
29 Oct 1992
Employees
9,666
Website
panvel.com ↗

Leadership

Pay as last reported

  • Mr. Julio Ricardo Andrighetto MottinChairman of the Board, since 2016
  • Mr. Julio Ricardo Mottin MottinChief Executive Officer, Member of the Executive Board, since 2016
  • Mr. Antonio Carlos Tocchetto NappChief Financial and Investor Relations Officer, since 2020
  • Mr. Roberto Coimbra SantosMember of the Executive Board, since 2016
  • Mr. Roberto Luiz WeberDirector, since 2016
  • Mr. Claudio Roberto ElyIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company employs 9,666 full-time staff members across its operations.
  • Dimed SA operates over 280 retail stores in three Brazilian states.
  • The firm owns distribution centers in five specific Brazilian states.

Weaknesses

  • The company is headquartered in Eldorado do Sul, a smaller city.
  • Business operations are concentrated in only three southern Brazilian states.
  • The firm relies heavily on retail and wholesale distribution channels.

Opportunities

  • Expanding the Medicine segment could increase overall revenue significantly.
  • Growing demand for cosmetics offers potential for higher profit margins.
  • Importing and exporting activities allow access to international markets.

Threats

  • Competition in the retail pharmaceutical sector remains intense and dynamic.
  • Economic fluctuations in Brazil may reduce consumer spending on cosmetics.
  • Regulatory changes in health care could impact medicine distribution costs.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.